Orchid Ventures Inc. (CSE:ORCD) and its wholly owned subsidiary, Orchid Essentials (“Orchid”, “Orchid Essentials”, the “Company”) (CSE: ORCD) (OTC: ORVRF) -California-based cannabis brand Orchid Essentials is pleased to announce that it has partnered with industry-leading media and public relations firm MATTIO Communications in an effort to build awareness of the Orchid Essentials brand. Orchid’s new partnership with MATTIO Communications positions the company to capitalize on the brand’s fast-growing presence in California and Oregon and help to make Orchid Essentials a household name throughout the United States.

MATTIO Communications recently completed a seed round of funding and is backed by investors including Phyto Partners, venture capital titan Alan Patricof (founder of Greycroft), and Green Seed Fund. Founded by Rosie Mattio in 2004, MATTIO is based in New York City and serves over 25 marquee cannabis clients, including Headset, Papa & Barkley, LeafLink, Flowhub, Caliva, Green Mile, and Ascend Wellness Holdings. The agency offers a wide spectrum of marketing services, including public relations, social media, SEO, and investor relations, and its new funding will help to expand the firm’s range of marketing and advertising services, including a targeted programmatic ad network.


About the partnership with MATTIO, Corey Mangold of Orchid comments: “Our partnership with Rosie and her amazing team at MATTIO has us thrilled about the future and further becoming a thought-leader in an industry that is seeing accelerated growth, and more excitingly, medical research and the development of a global marketplace. MATTIO’s experience in working in new and innovative industries has and will continue to allow Orchid Essentials to be top of mind, and on the forefront of the cannabis industry as it grows from its infancy.”

Orchid Ventures also announced that Chief Strategy Officer Eric Vaughan will be taking on the additional role of Chief Operating Officer, replacing Adam Mirkovich. The consolidation of these roles streamlines decision-making and provides the company with the right leadership structure for its next phase of growth. “Eric has proven to be an exceptionally talented operator in addition to a strategic thinker, which makes his promotion an obvious step forward for our company. I am excited to have Eric leading our operations teams and working with the staff to build culture and better processes as we execute our growth strategy,” stated Orchid Ventures CEO Corey Mangold.

About Orchid Ventures, Inc.

Based in Costa Mesa, CA, Orchid Ventures, Inc. launched the Orchid Essentials brand in Oregon and California in August 2017 and has since developed a mass-market brand and loyal consumer following with its premium vape products. Orchid’s products lines are currently sold in 400+ dispensaries across Oregon and California and are handcrafted and designed for maximum flavor and overall enjoyment. The company’s proven processes and passion for what it does carry through into its products. The end result is an unparalleled experience for new and practiced cannabis users alike. Orchid plans to expand its brand into new markets such as Nevada, New York, Puerto Rico, Canada, and other global markets. With a continued focus on brand and intellectual property development, Orchid will execute strategic acquisitions to solidify an integrated cannabis manufacturing and distribution infrastructure with the goal of becoming a dominant premium cannabis brand in the United States. Orchid’s leadership team brings significant branding, product development, manufacturing, and distribution experience with a proven track record of scaling revenues, building value generating partnerships, and creating enterprise value. Learn more at https://orchidessentials.com/.

About MATTIO Communications

Mattio Communications is an industry-leading strategic marketing firm. By specializing in the cannabis industry, the boutique-sized agency is able to offer a wide spectrum of marketing services: public relations, SEO, social media, content marketing, event production, influencer marketing, investor relations and programmatic media. The agency’s active involvement with its clients drives communication and marketing success. The Green Report ranked Mattio Communications #1 among Cannabis PR firms. Learn more at https://www.mattio.com/.

On Behalf of the Board of Directors
Corey Mangold
CEO and Director
investors@orchidessentials.com

Safe Harbor Statement

Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, as they relate to Orchid Ventures, Inc. and Orchid Essentials (collectively, the “Company”) or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company’s Canadian securities regulatory filings with sedar.com. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company’s ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management’s ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company’s Canadian securities regulatory filings with sedar.com. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Investor Relations
investors@orchidessentials.com

Click here to connect with Orchid Ventures Inc. (CSE:ORCD) for an Investor Presentation. 

  • Company has received UK Continuing Professional Development (“CPD”) accreditation for its global education platform, Khiron Academy
  • UK medical professionals may now earn CPD credits through Khiron’s medical cannabis education program
  • The Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK, to increase patient access via medical cannabis education
  • As a leading international medical cannabis educator, nearly 1,000 medical professionals in Latin America and the United Kingdom have registered for, or completed, Khiron Academy training

 Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe is pleased to announce it has received UK Continuing Professional Development (“CPD”) accreditation for Khiron Academy, the Company’s global medical cannabis education platform.

Additionally, following its accreditation, the Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK and fellow founding member of Project Twenty21, to increase patient access through medical cannabis education initially. Khiron Academy will be made available to prescribers in the UK that have registered with Cellen’s MedCanHub, an emerging education portal. Cellen is market leader, widely recognized for also launching the UK’s first digital pain clinic, Leva.

Keep reading... Show less

TRACE’s plant-based and alkaline wellness products to expand into key markets of Japan, China and the Philippines

Emerging leader in innovative health and wellness beverages and consumer products, BevCanna Enterprises Inc . ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today its anticipated expansion into the Asia Pacific region, through its wholly-owned subsidiary Naturo Group. After completing a comprehensive market, distribution and partner assessment, the Company intends to initially launch its portfolio of TRACE health and wellness products in the key markets of Japan, China, and the Philippines, through multi-channel distribution outlets including e-commerce, retail, and wholesale.

Keep reading... Show less

Trulieve acquires dispensary permits from Solevo Wellness West Virginia LLC for $650,000

Trulieve Cannabis Corp . (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States and the largest cannabis company in Florida announced today that it acquired Solevo Wellness West Virginia LLC (“Solevo”) and its three West Virginia dispensary permits for $650,000 . Solevo was awarded two permits in Morgantown and one in Parkersburg in January 2021 as part of the West Virginia application process.

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) a wellness company that develops and sells sustainable, plant-based products, is pleased to announce that it’s Jusu Home and Body line is now available for purchase on Faire Wholesale Marketplace (“Faire” or “www.faire.com”), an online wholesale marketplace valued at US $2.5 billion. Jusu Home and Body products are currently featured in their “New Arrivals” section.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/80230_8c77c54544bf884c_001.jpg

Keep reading... Show less

 Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) today announced that it has retained KCSA Strategic Communications (” KCSA “), a leading New York City -based communications firm.

Keep reading... Show less